FDA Proposes Inspection Of Injectable Products For Visible P

FDA and CDER have released a draft guidance addressing the development and implementation of a holistic, risk-based approach to visible particulate...

Related Keywords

Mark Durivage , Quality Systems Compliance , Drug Evaluation , Biologics Evaluation , Veterinary Medicine , Injectable Products , Visible Particulates , United States Pharmacopeia ,